ArticleBiochemical and biophysical research communications2026
Betaine supplementation prevents ethanol-induced disruption of intestinal tight junction integrity and liver inflammation in rats.
Article in Biochemical and biophysical research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hepatocyte-Specific Deletion of Betaine-Homocysteine Methyltransferase Disrupts Methionine Metabolism and Promotes the Spontaneous Development of Hepatic Steatosis.Biomolecules · 2026Article
- The Hidden Metabolites in Glutinous Rice Huangjiu and Their Antioxidant Potential.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAlcohol-associated liver disease (ALD) remains a significant health burden. In our previous studies, we have established that chronic ethanol consumption severely impairs the hepatic methionine metabolic pathway, most harmfully by reducing the critical ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH). This decline in the SAM:SAH ratio, or methylation index, impairs essential biological methylation reactions, which is a key driver of early ALD features. Furthermore, the integrity of the gut-liver axis is crucial in ALD; ethanol damages the intestinal barrier, leading to increased translocation of bacterial endotoxins into the liver and triggering inflammation. This study investigated whether betaine, an essential methyl group donor, could prevent both the intestinal barrier disruption and subsequent liver injury caused by ethanol.
methodsMale Wistar rats were pair-fed Lieber-DeCarli control or ethanol diets, with or without 1 % betaine supplementation, for eight weeks. We have examined intestinal tight junction (TJ) protein localization and barrier function in the ileum. Liver injury and inflammation were assessed via serum markers (AST, endotoxin) and hepatic cytokine expression (TNFα and CCL2).
resultsEthanol feeding resulted in disorganized TJ proteins, accompanied by increased serum endotoxin and elevated markers of liver injury and inflammation (AST, cytokines). Betaine supplementation prevented these intestinal disruptions, maintained barrier function, reduced endotoxin translocation, and significantly mitigated liver inflammation and injury, despite comparable blood alcohol levels.
conclusionBetaine effectively prevents ethanol-induced intestinal barrier breakdown and subsequent liver inflammation/injury by preserving the intestinal barrier. These results suggest strong therapeutic potential for betaine in managing ALD, warranting clinical investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.